# Core Scientific Inc. (CORZ) fundamentals

Data as of 2026-09-08. NASDAQ, United States. Sector: Technology. Price $17.89, market value $5.7 billion.

## Valuation
- **P/E (trailing): n/a** (negative earnings). Core Scientific Inc. reported negative earnings over the last twelve months, so the P/E is not meaningful; use price-to-sales, EV/EBITDA and free-cash-flow yield instead.
- **PEG: 1.56**. A PEG of 1.56 is in the range usually read as fairly priced for its growth.
- **Price / sales: 13.1×**. Each dollar of revenue is priced at 13.1×, a level that requires very high margins or very fast growth to justify.
- **Free-cash-flow yield: -16.7%** (5-yr avg -5.6%). Free cash flow is negative: the business is consuming cash, which is normal for heavy investment phases but a warning otherwise.

## Profitability
- **Gross margin: 28.3%**. Core Scientific Inc. keeps 28.3% of revenue after the direct cost of what it sells.
- **Operating margin: -127.4%**. Operating margin is negative: the business loses money before interest and tax.
- **Net margin: -90.5%**. The company reported a net loss over the last twelve months.
- **Return on equity: 30.0%**. 30.0% on shareholders' equity is excellent if it is not driven by leverage; sustained above 20% usually signals a competitive advantage.
- **Return on invested capital: 207.4%**. Return on all capital, debt included, is 207.4%: comfortably above what that capital costs.
- **Return on assets: -60.9%**. Each dollar of assets produces -60.9% of profit.

## Growth
- **Revenue growth (1 yr): -37.5%** (3-yr -20.7%/yr, 5-yr 39.5%/yr). Revenue fell 37.5% over the last year, against 39.5% a year compounded over five years: growth is slowing.
- **EPS growth (1 yr): 81.9%**. Earnings per share rose 81.9%, faster than revenue, so margins expanded or the share count shrank.

## Financial health
- **Net debt / EBITDA: net cash**. Core Scientific Inc. holds more cash than debt.
- **Altman Z-score: 0.26**. A Z-score of 0.26 is in the distress zone, a signal to examine the balance sheet closely.
- **Piotroski F-score: 3/9**. 3 of 9 checks pass: weak or deteriorating financials.

## Dividends
- **Dividend: none**. Core Scientific Inc. does not currently pay a dividend.

## Price and momentum
- **Total return (1 yr): 31.4%** (YTD 22.9%, 3-mo -30.8%). The shares are up 31.4% over twelve months including dividends.
- **From 52-week high: -41.3%** (34.0% above the low). Trading 41% below its 52-week high, deep in a drawdown.
- **200-day average: below**. The price sits below its 200-day moving average, the usual definition of a downtrend.
- **RSI (14-day): 44**. An RSI of 44 is neutral.
- **Beta (1 yr): 2.63** (volatility 71%). Beta of 2.63 against the S&P 500: the shares move much more than the market.

Live score and charts: https://foliofundamentals.com/analyzer?s=CORZ · Page: https://foliofundamentals.com/stocks/corz

Not investment advice.